Effect of Tocilizumab on Bone Outcomes in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis

BACKGROUND: Tocilizumab (TCZ), an interleukin-6 receptor inhibitor for rheumatoid arthritis (RA), may benefit bone metabolism. This meta-analysis aimed to synthesize the effects of TCZ on bone turnover markers (BTMs) and bone mineral density (BMD). METHODS: Cochrane Library, Embase, PubMed, Scopus, and Web of Science were searched from inception to 23 February 2025. Randomized controlled trials and observational studies comparing TCZ with controls and reporting BTMs or BMD were included. Pooled mean differences (MDs) or standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated. RESULTS: Eight studies involving 1,221 participants were included. TCZ significantly reduced C-terminal telopeptide of type I collagen (CTX-I) (MD = -0.05, 95% CI [-0.08, -0.02], P = 0.001; I2 = 0%) and carboxyterminal telopeptide of type I collagen (ICTP) (MD = -7.19, 95% CI [-12.39, -1.99], P = 0.007; I2 = 97%), and increased procollagen type I N-terminal propeptide (PINP) (SMD = 0.21, 95% CI [0.08, 0.34], P = 0.001; I2 = 0%). The overall effect on osteocalcin (OC) was not significant, whereas RCT subgroup analysis showed a significant increase (MD = 3.83, 95% CI [1.12, 6.54], P = 0.006). No significant improvement in femoral neck BMD or lumbar spine BMD was observed. CONCLUSIONS: TCZ may improve bone metabolism in RA by suppressing bone resorption and promoting bone formation. However, these biochemical changes did not translate into measurable increases in BMD during follow-up. Further long-term studies are warranted to clarify effects on BMD.

Authors

Institutions

Publication Details

Journal
Endocrine Connections
Published
2026-11-12
DOI
https://doi.org/10.1530/ec-26-0503
Primary Topic
Rheumatoid Arthritis Research and Therapies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Effect of Tocilizumab on Bone Outcomes in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis

Yushu Li, Zhongyan Shan, Weiping Teng, Deshi Chen et al.
Endocrine Connections
Rheumatoid Arthritis Research and Therapies
article

Effect of Tocilizumab on Bone Outcomes in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-analysis

Yushu Li, Zhongyan Shan, Weiping Teng, Deshi Chen, Siqi Tang, Feixue Jiang, Zhipeng Cui
article en

Abstract

BACKGROUND: Tocilizumab (TCZ), an interleukin-6 receptor inhibitor for rheumatoid arthritis (RA), may benefit bone metabolism. This meta-analysis aimed to synthesize the effects of TCZ on bone turnover markers (BTMs) and bone mineral density (BMD). METHODS: Cochrane Library, Embase, PubMed, Scopus, and Web of Science were searched from inception to 23 February 2025. Randomized controlled trials and observational studies comparing TCZ with controls and reporting BTMs or BMD were included. Pooled mean differences (MDs) or standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated. RESULTS: Eight studies involving 1,221 participants were included. TCZ significantly reduced C-terminal telopeptide of type I collagen (CTX-I) (MD = -0.05, 95% CI [-0.08, -0.02], P = 0.001; I2 = 0%) and carboxyterminal telopeptide of type I collagen (ICTP) (MD = -7.19, 95% CI [-12.39, -1.99], P = 0.007; I2 = 97%), and increased procollagen type I N-terminal propeptide (PINP) (SMD = 0.21, 95% CI [0.08, 0.34], P = 0.001; I2 = 0%). The overall effect on osteocalcin (OC) was not significant, whereas RCT subgroup analysis showed a significant increase (MD = 3.83, 95% CI [1.12, 6.54], P = 0.006). No significant improvement in femoral neck BMD or lumbar spine BMD was observed. CONCLUSIONS: TCZ may improve bone metabolism in RA by suppressing bone resorption and promoting bone formation. However, these biochemical changes did not translate into measurable increases in BMD during follow-up. Further long-term studies are warranted to clarify effects on BMD.

Endocrine Connections
First Hospital of China Medical University (CN)
Good health and well-being
Rheumatoid Arthritis Research and Therapies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon